Tenders of Dak Gesundheit
Tenders of Dak Gesundheit
DAK Gesundheit Tender
Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountEUR 1 (USD 1)
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Olanzapin (ausschl. Dafo. Zur Herstellung Einer Depot - Isu, Atc N05ah03 (obo) F. D. Z. 01.08.24 - 31.07.26
DAK Gesundheit Tender
Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountRefer Documents
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient ustekinumab, Atc L04ac05 (obo) for the period 01.08.2024 - 31.07.2025 (plus extension option 1x12 months)
DAK Gesundheit Tender
Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountEUR 1 (USD 1)
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Omalizumab, Atc R03dx05 (obo) Für Die Zeit 01.08.2024 - 31.07.2025 (zzgl. Verlängerungsoption 1x12 Monate)
DAK Gesundheit Tender
Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountEUR 1 (USD 1)
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Bimatoprost + Timolol (ausschließlich Edo), Atc S01ed62 (obo) Für Die Zeit 01.08.2024 - 31.07.2026
DAK Gesundheit Tender
Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountRefer Documents
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient bimatoprost + timolol (exclusively Edo), ATC S01ed62 (obo) for the period 01.08.2024 - 31.07.2026
DAK Gesundheit Tender
Healthcare and Medicine...+1Chemical Products
Germany
Closing Date5 Jun 2026
Tender AmountRefer Documents
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient fesoterodine, ATC G04bd11 (obg) for the period 01.08.2024 - 31.07.2026
DAK Gesundheit Tender
Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountRefer Documents
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient lisdexamfetamine, ATC N06ba12 (obg) for the period 01.08.24 - 31.07.25 (plus extension option 1x12 months)
DAK Gesundheit Tender
Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountRefer Documents
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Omalizumab, Atc R03dx05 (obo) for the period 01.08.2024 - 31.07.2025 (plus extension option 1x12 months)
141-150 of 331 active Tenders